Insider · CIK 0001819427

Deck Kelly

Reports to the SEC for 2 companies · LA JOLLA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001819427

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-01	INBXInhibrx Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+15K sh	—	—	15,000
2024-05-30	Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−9,167 sh	—	—	0
2024-05-30	Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−14.6K sh	—	—	0
2024-05-30	Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−21.3K sh	—	—	0
2024-05-30	INBXInhibrx Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+175K sh	—	—	175,000
2024-05-06	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−17.6K sh	$34.24	−$603K	0
2024-05-06	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,087 sh	$34.24	−$71.5K	0
2024-03-26	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−396 sh	$35.40	−$14K	17,624
2024-03-26	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−416 sh	$35.40	−$14.7K	9,167
2024-03-26	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,459 sh	$35.40	−$51.6K	14,583
2024-03-26	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−625 sh	$35.40	−$22.1K	21,250
2024-03-22	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−110 sh	$35.00	−$3,850	18,020
2024-03-21	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,113 sh	$35.09	−$109K	18,130
2024-03-20	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−16.8K sh	$35.02	−$588K	21,243
2024-03-13	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−32.4K sh	$35.43	−$1.15M	2,087
2024-03-08	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−42.5K sh	$35.75	−$1.52M	38,020
2024-03-05	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10.4K sh	$35.72	−$372K	9,583
2024-03-04	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,125 sh	$35.60	−$289K	21,875
2024-03-04	Inhibrx, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−54K sh	$35.40	−$1.91M	16,042
2023-01-03	Inhibrx, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2022-01-11	Inhibrx, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000
2021-01-15	Inhibrx, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
Apr 24
Deck Kelly0002007919-25-000037
SEC(opens sec.gov)
May 304
Deck Kelly0000950142-24-001496
SEC(opens sec.gov)
May 304
Deck Kelly0000950142-24-001489
SEC(opens sec.gov)
May 84
Deck Kelly0001739614-24-000023
SEC(opens sec.gov)
Mar 284
Deck Kelly0001739614-24-000021
SEC(opens sec.gov)
Mar 224
Deck Kelly0001739614-24-000019
SEC(opens sec.gov)
Mar 154
Deck Kelly0001739614-24-000015
SEC(opens sec.gov)
Mar 124
Deck Kelly0001739614-24-000011
SEC(opens sec.gov)
Mar 64
Deck Kelly0001739614-24-000009
SEC(opens sec.gov)
Jan 34
Deck Kelly0001739614-23-000002
SEC(opens sec.gov)

Companies

Address

C/O INHIBRX BIOSCIENCES, INC. 11025 NORTH TORREY PINES ROAD, SUITE 140

LA JOLLA, CA, 92037